Should CD19 CAR-T Cells for ALL be Followed by Allogeneic Stem Cell Transplant?

Carlos A Ramos1

  • 1Center for Cell and Gene Therapy, Houston Methodist Hospital, Texas Children's Hospital and Baylor College of Medicine, Hematology-Oncology Section, Department of Medicine, Baylor College of Medicine, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.

Abstract

No abstract available in PubMed .